Subacute-Aggressive-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy as the Initial Presentation in a Pediatric Patient With Systemic Lupus Erythematosus: A 5-Year Follow-Up Case Report

References

[1] J. G. Hanly, Q. Li, L. Su, et al., “Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study,” Arthritis & Rheumatology 72, no. 1 (2020): 67–77.

[2] P. Toledano, R. Orueta, I. Rodríguez-Pintó, J. Valls-Solé, R. Cervera, and G. Espinosa, “Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: Prevalence, Clinical and Immunological Characteristics, Treatment and Outcome of a Large Cohort From a Single Centre,” Autoimmunity Reviews 16, no. 7 (2017): 750–755.

[3] P. Y. K. Van den Bergh, P. A. van Doorn, R. D. M. Hadden, et al., “European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force—Second Revision,” Journal of the Peripheral Nervous System 26, no. 3 (2021): 242–268.

[4] P. R. Julio, M. De Miranda Moura Cortês, L. T. L. Costallat, J. Z. Gaino, M. C. França, and S. Appenzeller, “Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Systemic Lupus Erythematosus,” Seminars in Arthritis and Rheumatism 51, no. 1 (2021): 158–165.

[5] M. Aringer, K. Costenbader, D. Daikh, et al., “European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus,” Annals of the Rheumatic Diseases 78, no. 9 (2019): 1151–1159.

[6] H. C. Lehmann, D. Burke, and S. Kuwabara, “Chronic Inflammatory Demyelinating Polyneuropathy: Update on Diagnosis, Immunopathogenesis and Treatment,” Journal of Neurology, Neurosurgery, and Psychiatry 90, no. 9 (2019): 981–987.

[7] Y. Aotsuka, S. Misawa, T. Suichi, et al., “Prevalence, Clinical Profiles, and Prognosis of CIDP in Japanese Nationwide Survey: Analyses of 1,257 Diagnosis-Confirmed Patients,” Neurology 102, no. 6 (2024): e209130.

[8] M. A. Zoilo, B. Eduardo, F. Enrique, and M. V. M. del Rocio, “Chronic Inflammatory Demyelinating Polyradiculoneuropathy in a Boy With Systemic Lupus Erythematosus,” Rheumatology International 30, no. 7 (2010): 965–968.

[9] L. A. Querol, H.-P. Hartung, R. A. Lewis, et al., “The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies,” Neurotherapeutics 19, no. 3 (2022): 864–873.

[10] X. Dai, Y. Fan, and X. Zhao, “Systemic Lupus Erythematosus: Updated Insights on the Pathogenesis, Diagnosis, Prevention and Therapeutics,” Signal Transduction and Targeted Therapy 10, no. 1 (2025): 102.

[11] A. Bortoluzzi, E. Silvagni, F. Furini, M. Piga, and M. Govoni, “Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Review of the Evidence,” Clinical & Experimental Rheumatology 37, no. 1 (2019): 146–155. Epub 2018 May 24. PMID: 29846158.

[12] J. Wang, Z. Zhang, J. Qian, et al., “Clinical Features of Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuritis Associated With SLE,” Lupus Science & Medicine 11, no. 2 (2024): e001244.

RIGHTS & PERMISSIONS

2025 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.